CSL - CSL Limited

[Judd]

CSLDA is the code.

 

[Gurgler]

Thanks very much Judd; there was probably notification of that somewhere but I missed it in my malaise. Cheers.

 

[brilliantmichael]

Haha At least I know there's somebody out there who also uses Westpac! Haha.

Gurgler and Judd what do you think of our "beloved" Westpac's brokerage rates? Would you say they're competitive?

 

[Prospector]

OK, so what happens now, I am with NAB, and CSL shows as zero, with no mention of CSLDA. The portfolio looks a bit sick without it. When will it show up?

The last stock split I had was with Gunns - except that time my holding doubled until NAB worked it out.

 

[Judd]

Absolutely amazing. One of the better managed and innovative companies on the ASX which reported today and not a word from the ASF brighter sparks. Dead since October 2007 until this post. What a shame.

I suppose the wanna's are too tied up with perceived gains to be made from properties or resources minnows to care.

 

[Prospector]

Hey Judd, if you do a track back through this thread, that has been the story of CSL for a long time. Maybe it is too much an ethical share? Sometimes seems like I am the only one following it. Yet for me I have held since the price of $37, rose to almost $100, then the split issue. So not only makes you feel good by its benefits to mankind, but has made me some nice money too.
You know, it only prevents cancer, doesnt have any other glitz to it.

 

[Judd]

So not only makes you feel good by its benefits to mankind, but has made me some nice money too.
You know, it only prevents cancer, doesnt have any other glitz to it.

True on both points. And the blood products it makes and provides are even less glitzier. Strange world.

Also I have read that Gardasil is also effective for older women, so there is another avenue for income for CSL. Mind you, if it were provided to older women, I am sure Family First and others will claim that it will turn these gentle creatures into promiscuous *****s as it already does for "young gels." Like who cares if assists in preventing a truly awful disease.

 

[michael_selway]

Hey Judd, if you do a track back through this thread, that has been the story of CSL for a long time. Maybe it is too much an ethical share? Sometimes seems like I am the only one following it. Yet for me I have held since the price of $37, rose to almost $100, then the split issue. So not only makes you feel good by its benefits to mankind, but has made me some nice money too.
You know, it only prevents cancer, doesnt have any other glitz to it.

Thing is never understimate a biotech, they coudl coem up with new geart medicines & vaccines at any time

Earnings and Dividends Forecast (cents per share)
2007 2008 2009 2010
EPS 96.8 122.4 159.8 197.3
DPS 34.3 44.0 55.0 70.0

thx

MS

 

[Knobby22]

A lot of us just sit back smiling and don't feel any need to "push" it.
A beautiful company that can survive and prosper even during major shocks to the economy.

I find it interesting that the buyback may not occur because McNamee is keeping his eye out for a bargain.

 

[brendan87]

I agree. I look at CSL as a kind of "quiet achiever".

But perhaps the lack of popularity could be due to its 75% fall from grace post-9/11 when it went from market darling, tripling in under 2 years, to dog after the plasma glut in 01/02.

That would have sworn some l-t investors and trader alike off CSL for life, especially given its 'blue-chip' status. Few top 20 companies can boast such as a rapid and severe fall in SP in recent history.

But that's not to rag CSL, I'm a happy holder from $48 (pre-split) so I've doubled my $$ on this beauty!

 

[Gurgler]

This from FN Arena today:

Time For A Pull Back For CSL, Says Tech Wizard
FN Arena News - March 13 2008

The Tech Wizard has noted that shares of CSL (CSL) have held up quite well over the past six months despite all the market turmoil and many an other stock being hammered throughout the market correction. However, the Wizard also believes that the time for a pull back has finally arrived for CSL.


Having spiked above the top Bollinger band twice, forming a so-called Tweezer top candle stick reversal pattern, price action is now at the 20 moving average (M/A) and should continue to hover down to test the lower Bollinger band at $32.00, he says.


The good news is there is good support at $31.00, he says. He doesn't see any reason why that shouldn't hold.


The Tech Wizard has informed us he doesn't own shares in the company.

However I guess we'll just continue the sideways movement of the past 5 months, some more after that!

 

[nizar]

Hi,

Does anybody have, or know where I could find, an un-adjusted (longterm) chart for this champion?

 

[Spineli]

Here is a long-term chart incorporating the share split.

Had the share split not occurred, its share price would have been competing with IPL for the highest priced local stock.

 

[MichaelD]

This from FN Arena today:

Time For A Pull Back For CSL, Says Tech Wizard
FN Arena News - March 13 2008

The Tech Wizard has noted that shares of CSL (CSL) have held up quite well over the past six months despite all the market turmoil and many an other stock being hammered throughout the market correction. However, the Wizard also believes that the time for a pull back has finally arrived for CSL.


Having spiked above the top Bollinger band twice, forming a so-called Tweezer top candle stick reversal pattern, price action is now at the 20 moving average (M/A) and should continue to hover down to test the lower Bollinger band at $32.00, he says.


The good news is there is good support at $31.00, he says. He doesn't see any reason why that shouldn't hold.

Just happened upon this little gem of a quote.


Analysis on 13-Mar-2008 from guru.

- candlestick reversal pattern
- should continue to hover down to test the lower Bollinger band at $32.
- support at $31.


What ACTUALLY happened.

Basically it has gone straight up. The EXACT date of the bottom was in fact the day this analysis was published.


The lesson? Analysts are very good at predicting the past.

 

[Caliente]

Hi - just got a report from CSL fresh from my broker (ML) [15/07/08].

"Multiple compression accelerated on HPV unwarranted
In the past six weeks CSL has fallen 15.5% with its FY09 PE compressing to
20.9x (from 24.7x) despite a market fall of only 13.8% and comparables such as Baxter and Grifols both gaining 6.9% (PE 18.8x) and 2.1% (PE 27.3x) respectively. As previously highlighted the sensitivity to a HPV low case given recent concern is only -1.3% in FY09. Hence the accelerated compression relative to CSL’s peer group, and that of the market (given CSL’s growth profile), appears to us unwarranted. Buy recommendation and $45.00/ share PO maintained We continue to see upside risk on earnings leverage to new plasma sales, commercialisation of R&D and acquisitive growth opportunities in plasma or immunology. Downside risk is present in currency earnings expectations."

They like it to a price objective of $45 in 12 months.

My strategy is to start diversifying out of the resources game and into good quality defensives. CSL with its strong cash position, expanding profits, and position in healthcare (one of the last areas of economy to be compromised)
fits the bill.

Picked up a 1000 units this morning.

Cheers
-Cali

 

[michael_selway]

Hi - just got a report from CSL fresh from my broker (ML) [15/07/08].

"Multiple compression accelerated on HPV unwarranted
In the past six weeks CSL has fallen 15.5% with its FY09 PE compressing to
20.9x (from 24.7x) despite a market fall of only 13.8% and comparables such as Baxter and Grifols both gaining 6.9% (PE 18.8x) and 2.1% (PE 27.3x) respectively. As previously highlighted the sensitivity to a HPV low case given recent concern is only -1.3% in FY09. Hence the accelerated compression relative to CSL’s peer group, and that of the market (given CSL’s growth profile), appears to us unwarranted. Buy recommendation and $45.00/ share PO maintained We continue to see upside risk on earnings leverage to new plasma sales, commercialisation of R&D and acquisitive growth opportunities in plasma or immunology. Downside risk is present in currency earnings expectations."

They like it to a price objective of $45 in 12 months.

My strategy is to start diversifying out of the resources game and into good quality defensives. CSL with its strong cash position, expanding profits, and position in healthcare (one of the last areas of economy to be compromised)
fits the bill.

Picked up a 1000 units this morning.

Cheers
-Cali

Yep looks good CSL

Earnings and Dividends Forecast (cents per share)
2007 2008 2009 2010
EPS 96.8 127.7 161.2 200.0
DPS 34.3 48.0 57.0 69.8


thx

MS

 

[Judd]

Was the result and activity from CSL so ordinary that it does not rate a mention on ASF - apart from this one?

If successful with the purchase it probably will have around 25% of the world's plasma production.

 

[Knobby22]

Was the result and activity from CSL so ordinary that it does not rate a mention on ASF - apart from this one?

If successful with the purchase it probably will have around 25% of the world's plasma production.

Good buy during high Aussie dollar credit crunch and avoiding the dodgy US stock market.

However... last time McNamee bought big the share price got the wobbles before it recovered. These big investors often don't have enough long term focus.

 

[Bruza]

Was the result and activity from CSL so ordinary that it does not rate a mention on ASF - apart from this one?

If successful with the purchase it probably will have around 25% of the world's plasma production.

Yes Judd,

I was hoping to find some discussion about the pros & con's re the SPP.

I would be interested to hear of other (average) investor's thoughts on the Plan.

Personally I am considering $3000 worth, as have often thought "I would like
to increase my holdings in this Co.", given the opportunity.

I have given it a through "health test" & it comes out a big winner, also compared to XJO on a percentage basis over the last year, come out way in front.

 

[mshepherd]

It looks similar to the GDY SPP set-up of a few months ago, i.e. The price held above the SPP price until the day of issue, whereby it fell to about the offer price then gravitated around that price for a while. It has now dropped quite a bit below the SPP, so there is no reason CSL cannot do the exact same thing. Its a great company with great potential, although GDY was the same and also got a huge number of share holders taking up the SPP and also gave out quite a few free options aswell, GDY has since dropped. Yes it seems like a good offer, although there have been others similar (or even more attractive) which have since fallen substantialy.

I wonder if a way to play this would be to wait until after the shares are issued and hope that some are offloaded cheaply? on the other hand CSL's recent aquisition is valuable and the company has a well worn up trend - look at the 5 year chart, also fundamentals of an ageing population may help boost their industry. As like GDY, CSL seem to be amongst the leaders of exciting and promosing technologies, aka zero-emmission energy and biotech.

I think ill once again wait to the last moment before deciding whether to sign up to the SPP.